Cure8 news brief
Cure8 news brief
Identifies gene and microbiome patterns linked to progression from inflammation to irreversible bowel fibrosis in Crohn’s disease, which could eventually help predict who is at higher risk and inform prevention strategies.
Adults with Crohn’s disease, clinicians managing Crohn’s (especially those concerned with fibrosis/strictures), and researchers working on biomarkers, microbiome, or AI applications in IBD.
Researchers analyzed 448 intestinal tissue transcriptomes and 80 microbiome samples across healthy controls, Crohn’s disease and fibrotic Crohn’s disease and applied machine learning augmented with generative AI to expand datasets and improve model performance.
They report three major biological patterns associated with fibrosis: persistent immune activation, loss of normal bowel function, and ongoing tissue stress and barrier weakening. Microbiome shifts included loss of short-chain fatty-acid–producing bacteria and increases in taxa such as Bilophila and Bacteroides.
The team highlights several fibrosis-associated genes (noted in the article: IL-23R, TNF-α, TGF-β) that overlap with known inflammatory and fibrotic pathways. The authors present these molecular signatures as potential biomarkers for distinguishing active inflammation from irreversible scarring and for future targeted therapies.
This study used generative AI to create synthetic gene-expression data to boost machine-learning analyses because fibrosis samples were limited. Results are hypothesis-generating and need external validation before changing clinical care.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.